AI assistant
Zelluna ASA — Share Issue/Capital Change 2021
Mar 11, 2021
3779_rns_2021-03-11_b496150d-87ce-4212-95bd-bec116fed9db.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Ultimovacs ASA: New share capital registered
Ultimovacs ASA: New share capital registered
Oslo, 11 March 2021, Ultimovacs ASA (the "Company") refers to the announcement published on 8 March 2021 regarding the issuance of new shares in connection with the Company's employee incentive program.
The share capital increase related to the share issue has been registered in the Norwegian Register of Business Enterprises, and the Company's new share capital is NOK 3,200,326.10, divided into 32,003,261 shares, each with a par value of NOK 0.10.
For further information, please contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: [email protected]
Phone: +47 480 96 355
Carlos de Sousa, CEO
Email: [email protected]
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: [email protected]
Phone: +47 482 48632